Viewing Study NCT03518203

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:43 PM
Ignite Modification Date: 2026-02-10 @ 2:00 PM
Study NCT ID: NCT03518203
Status: COMPLETED
Last Update Posted: 2023-09-21
First Post: 2018-03-05
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
Sponsor: Children's Hospital Medical Center, Cincinnati
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thrombotic Microangiopathies View
None Atypical Hemolytic Uremic Syndrome View
None Multiple Organ Dysfunction Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hematopoietic Stem Cell Transplant View